Thursday 14 November
Leaders Evolving and Developing (L.E.A.D.) Program – Bootcamp 1.0
Date: Thursday 14 November
Time: 0830 – 1700
SHPA Member: $235 incl GST
Non-member: $370 incl GST
Location: Gold Coast Convention and Exhibition Centre
Pharmacists and technicians promoted into leadership and management positions often find themselves challenged by tasks and responsibilities for which they lack specific training. This bootcamp will develop critical skills pharmacy staff must possess in order to be effective managers and leaders. It includes how to build and leverage key relationships within the organisation, build effective teams within their departments, lead and develop staff members, establish and implement new programs and services, track performance, and develop strategic plans for their departments.
Areas of focus for this program will include:
- Action-oriented strategic planning for managers to turn environmental changes into sustainable services and outcomes
- Accountability and pharmacy finance for leadership success
- Alignment of skills and strengths to build your team to meet the demands of tomorrow
- Advancing pharmacy practice through excellence in technician staffing models
Supported by our Strategic Partner, Roche
Competency Standards* addressed
- Standard 2.3.1 Use appropriate communication skills
- Standard 2.3.2 Confirm the effectiveness of communication
- Standard 4.3.1 Inspire a strategic vision and purpose
- Standard 4.3.2 Foster initiative and contribute to innovation, improvement and service development
- Standard 4.3.3 Encourage, influence and facilitate change
- Standard 4.4.1 Undertake strategic and/or operational planning
- Standard 4.4.2 Develop a business plan and monitor performance
- Standard 4.4.3 Establish suitable premises and infrastructure
- Standard 4.5.1 Plan and manage finances
- Standard 4.6.2 Establish role clarity and performance standards
- Standard 4.7.1 Understand and contribute to organisational/corporate and clinical governance
- Standard 4.7.2 Support and assist implementation of healthcare priorities
- Standard 4.7.3 Undertake project management
- Standard 4.7.4 Contribute to professional activities planning with consideration of strategic context
*National Competency Standards Framework for Pharmacists in Australia, 2016
Accreditation information
This activity has been accredited for 3.25 hours of Group-1 CPD (or 3.25 CPD credits) and 3 hours of Group-2 CPD (or 6 CPD credits) for a total of 9.25 CPD credits, suitable for inclusion in an individual pharmacist’s CPD plan. The accreditation number is S2019/70.
Heart Failure: Preserved or Reduced
Facilitated by the Cardiology Leadership Committee
Date: Thursday 14 November
Time: 0830 – 1230
SHPA Member: $175 incl GST
Non-member: $230 incl GST
Location: Gold Coast Convention and Exhibition Centre
This half day pre-conference session will discuss the current therapies for managing Heart Failure. It will highlight the different approaches to management of those with preserved ejection fraction and those with reduced ejection fraction. The first session will discuss the management of the patient with reduced ejection fraction, presented by Dr Kuljit Singh on how he manages these patients. Professor Scott McKenzie will follow this with a discussion on the management of patients with preserved ejection fraction, discussing the possibilities that may arise from ongoing trials.
The interactive workshops will be driven by Clinical Pharmacists already involved in multidisciplinary heart failure programs. They will highlight the specific roles for specialist pharmacist input in the management of patients with heart failure in both hospital and community settings.
Supported by Novartis
Competency Standards* addressed
- Standard 3.1.2 Assess medication management practices and needs
- Standard 3.1.3 Collaborate to develop a medication management strategy or plan
- Standard 3.3.1 Undertake a clinical review
- Standard 3.3.2 Apply clinical review findings to improve health outcomes
- Standard 4.7.6 Work across service delivery boundaries
Accreditation information
This activity has been accredited for 2 hours of Group-1 CPD (or 2 CPD credits) and 1.5 hours of Group-2 CPD (or 3 CPD credits), for a total of 5 CPD credits, suitable for inclusion in an individual pharmacist’s CPD plan. The accreditation number is S2019/88.
Engaging in Feedback Processes
Facilitated by the Education and Educational Visiting Leadership Committee
Date: Thursday 14 November
Time: 0830 – 1230
SHPA Member: $175 incl GST
Non-member: $230 incl GST
Location: Gold Coast Convention and Exhibition Centre
Feedback is the key to learning, but research suggests that feedback in the health professions is less useful than liked. There are a number of myths about feedback that continue to be propagated.
Three of these will be covered in the workshop:
- Feedback needs praise-criticism balancing rules
- Feedback is a skill residing within the teacher
- Feedback is an input process
These myths perpetuate unproductive rituals, discrete episodes of educators ‘telling’ that are backward facing. This workshop will offer alternative practical perspectives on these myths.
Our orienting principles are that:
- Feedback should be dynamic and co-constructed
- Students should be encouraged to be agentic through interpreting and making use of feedback information (“feedback literacy”)
- Feedback should develop students’ capacity to make judgements about the quality of their work.
These principles reposition feedback as a co-constructed socio-cultural student-led process, where they make sense of information along a learning trajectory. Here feedback is a process and it makes a difference.
Equipping learners to engage in feedback processes may reduce the emotional burden on both parties, rendering techniques such as the feedback sandwich redundant. This workshop will also highlight the benefits for both learners and teachers in conceptualising feedback as a relational activity and in tracing its effects. These effects may be immediate or latent, and include changes in learner evaluative judgement, motivation, clinical performance or professional identity.
Competency Standards* addressed
- Standard 2.3.1 Use appropriate communication skills
- Standard 2.4.2 Engage with others as appropriate to resolve the identified problem or issue
- Standard 4.1.2 Apply reflective skills for self-assessment
- Standard 4.3.4 Serve as a role model, coach and mentor for others
- Standard 4.6.5 Manage interpersonal relationships with supervised staff
*National Competency Standards Framework for Pharmacists in Australia, 2016
Accreditation information
This activity has been accredited for 0.5 hours of Group-1 CPD and 3 hours of Group-2 CPD (for a total of 6.5 CPD credits), suitable for inclusion in an individual pharmacist’s CPD plan. The accreditation number is S2019/64.
Principles of Geriatric Medicine in Practice Workshop
Facilitated by the Geriatric Medicine Leadership Committee
Date: Thursday 14 November
Time: 1330 – 1730
SHPA Member: $175 incl GST
Non-member: $230 incl GST
Location: Gold Coast Convention and Exhibition Centre
This session is designed to help pharmacists understand and apply geriatric medicine principles of care to the management of frail older people in non-geriatric care settings (e.g. general medicine wards, cardiology wards, etc). The workshop will enhance participants’ decision-making skills around prescribing, particularly medication review and deprescribing for frail older people. It will help them to incorporate factors such as patient’s values and goals of care, quality of life, life expectancy, multimorbidity, treatment burden and risk of adverse effects into their practice. The session will also introduce the SHPA Standard of Practice in Geriatric Medicine for Pharmacy Services which will be available later this year. The format will include short presentations followed by a case-based panel discussion. In this highly interactive session, we will follow the journey of a person from being a relatively fit older adult to a frail older adult and subsequent changes in treatment goals.
Competency Standards* addressed
- Standard 3.1.2 Assess medication management practices and needs
- Standard 3.2.3 Dispense medicines (including compounded medicines) in consultation with the patient and/or prescriber
- Standard 4.2.1 Work with established systems
- Standard 5.3.3 Apply research evidence into practice
*National Competency Standards Framework for Pharmacists in Australia, 2016
Accreditation information
This activity has been accredited for 2.5 hours of Group-1 CPD and 1 hour of Group-2 CPD (for a total of 4.5 CPD credits), suitable for inclusion in an individual pharmacist’s CPD plan. The accreditation number is S2019/62.
Paediatrics and Neonatology and Women’s and Newborn Health
Facilitated by the Paediatrics and Neonatology and Women’s and Newborn Health Leadership Committees
Full day registration (includes collaborative morning session and one afternoon session):
Date: Thursday 14 November
Time: 0830 – 1630
SHPA Member: $260 incl GST
Non-member: $370 incl GST
Location: Gold Coast Convention and Exhibition Centre
The morning sessions are intended to examine a range of topics that are applicable to women, newborns, paediatrics and neonatology. The focus will be to provide insights for challenging and emerging areas of clinical practice specific for these patient populations. Electronic medicines management is key to safely managing medications in clinical care. When designing and improving these systems, there are important obstetric, neonatal and paediatric considerations. There is increasing use of novel, off-label and complex medications in obstetric, paediatric and neonatal patients. In clinical pharmacy services we need to ensure judicious prescribing, learn to navigate principles to apply when evaluating the evidence, and ensure we have established procedures in place to safeguard these systems.
Half day registration (one afternoon session only):
Date: Thursday 14 November
Time: 1330 – 1645
SHPA Member: $175 incl GST
Non-member: $230 incl GST
Location: Gold Coast Convention and Exhibition Centre
The afternoon Women’s and Newborn Health session will include a focus on key considerations for managing neonatal hypoxic ischaemic encephalopathy and seizures, medication management challenges related to epilepsy in pregnancy, and an overview of pain management in delivery and the postpartum. There will also be the opportunity to hear the latest research related to Women’s and Newborns Health.
The Paediatrics and Neonatology afternoon breakout session will focus on a range of topics highlighting the ever expanding role of the paediatric pharmacist in a variety of specialist inpatient and ambulatory care settings. Paediatric pharmacists are breaking new ground by expanding their clinical role to the outpatient clinics, demonstrating the valuable impact early medication review and feedback can have for patients in ambulatory care settings. Childhood immunisation and antimicrobial allergy de-labelling are some of the most effective antimicrobial stewardship strategies to reduce infection burden and combat antimicrobial resistance. Both sessions will focus on practical ways the paediatric pharmacist can improve patient care and outcomes as part of a specialist multi-disciplinary team. Managing infectious complications in vulnerable paediatric patients can be tricky. This session will focus on the management of these complications, as well as the increasing use of novel, off-label and complex medications in paediatric transplant patients.
Accreditation information (morning)
This activity has been accredited for 3.75 hours of Group-1 CPD (or 3.75 CPD credits) and 1 hour of Group-2 CPD (or 2 CPD credits) for a total of 5.75 CPD credits, suitable for inclusion in an individual pharmacist’s CPD plan. The accreditation number is S2019/85.
Competency Standards* addressed
- Standard 1.3.1 Comply with statute law, guidelines, codes and standards
- Standard 1.3.4 Assist individuals to understand and grant informed consent
- Standard 3.1.2 Assess medication management practices and needs
- Standard 3.1.3 Collaborate to develop a medication management strategy or plan
- Standard 3.3.1 Undertake a clinical review
- Standard 3.3.2 Apply clinical review findings to improve health outcome
- Standard 3.6.3 Support evidence-based public health programs
- Standard 4.2.1 Work with established systems
- Standard 4.4.5 Develop and maintain supporting systems and strategies
- Standard 4.7.4 Contribute to professional activities planning with consideration of strategic context
- Standard 4.7.6 Work across service delivery boundaries
- Standard 5.2.3 Undertake critical evaluation activities
- Standard 5.3.3 Apply research evidence into practice
*National Competency Standards Framework for Pharmacists in Australia, 2016
Competency Standards* addressed (Paediatrics and Neonatology)
- Standard 3.1.2 Assess medication management practices and needs
- Standard 3.3.2 Apply clinical review findings to improve health outcomes
- Standard 3.6.3 Support evidence-based public health programs
- Standard 4.4.5 Develop and maintain supporting systems and strategies
- Standard 4.7.4 Contribute to professional activities planning with consideration of strategic context
- Standard 4.7.6 Work across service delivery boundaries
*National Competency Standards Framework for Pharmacists in Australia, 2016
Accreditation information (Paediatrics and Neonatology)
This activity has been accredited for 2.75 hours of Group-1 CPD (or 2.75 CPD credits), suitable for inclusion in an individual pharmacist’s CPD plan. The accreditation number is: S2019/74.
Competency Standards* addressed (Women’s and newborn health)
- Standard 3.1.2 Assess medication management practices and needs
- Standard 3.3.1 Undertake a clinical review
- Standard 3.3.2 Apply clinical review findings to improve health outcomes
- Standard 3.1.3 Collaborate to develop a medication management strategy or plan
*National Competency Standards Framework for Pharmacists in Australia, 2016
Accreditation information (Women’s and newborn health)
This activity has been accredited for 2.75 hours of Group-1 CPD (or 2.75 CPD credits), suitable for inclusion in an individual pharmacist’s CPD plan. The accreditation number is: S2019/86.
Voluntary Assisted Dying
Facilitated by the Palliative Care Leadership Committee
Date: Thursday 14 November
Time: 1300 – 1700
SHPA Member: $175 incl GST
Non-member: $230 incl GST
Location: Gold Coast Convention and Exhibition CentreVoluntary Assisted Dying (VAD) is now a choice for citizens of some states of Australia, with other states undergoing reviews of public and stakeholder’s opinions to develop recommendations. It is important that healthcare professionals understand their professional responsibilities with respect to this change in legislation.
This session aims to give context to the law by discussing what VAD is and isn’t, a global background, the state-based laws governing VAD, and the role and practical implications for pharmacists. This will not be a session debating the merits or otherwise of this end of life choice.
Competency Standards* addressed
- Standard 1.2.1 Support ethical professional practice
- Standard 1.3.1 Comply with statute law, guidelines, codes and standards
- Standard 1.4.1 Adopt a scope of practice consistent with competence
- Standard 2.1.1 Respect the personal characteristics, rights, preferences, values, beliefs, needs and cultural and linguistic diversity of patients and other clients, including Aboriginal and Torres Strait Islander peoples
- Standard 2.1.2 Support and respect the rights of patients and other clients to contribute to decision-making
- Standard 3.1.2 Assess medication management practices and needs
- Standard 4.1.1 Display emotional awareness and effective self-regulation of emotions
- Standard 4.1.2 Apply reflective skills for self-assessment
*National Competency Standards Framework for Pharmacists in Australia, 2016
Accreditation information
This activity has been accredited for 3 hours of Group-1 CPD (or 3 CPD credits), suitable for inclusion in an individual pharmacist’s CPD plan. The accreditation number is S2019/61.